Adverse Events Module
For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
Adverse Events Module
Event Groups
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Group 1: Cholecalciferol | Patients in this group have low vitamin D levels and Chronic Kidney Disease (CKD). Patients will be randomized to group 1 or group 2. Cholecalciferol: Cholecalciferol tablet, 50,000 units twice a week | None | None | 0 | 15 | 0 | 15 | View |
| Group 2: Calcitriol | Patients in this group have low vitamin D levels and Chronic Kidney Disease (CKD). Patients will be randomized to group 1 or group 2. calcitriol: calcitriol 0.25 mcg every day | None | None | 0 | 17 | 1 | 17 | View |
| Group 3: Cholecalciferol | Patients in this arm have low vitamin D levels and normal kidney function. They will be put into group 3. Cholecalciferol: Cholecalciferol tablet, 50,000 units twice a week | None | None | 0 | 24 | 1 | 24 | View |